Analysts Set Trupanion, Inc. (NASDAQ:TRUP) PT at $44.67

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven analysts that are covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $44.67.

A number of research analysts have weighed in on TRUP shares. Piper Sandler raised their price objective on shares of Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Bank of America raised their price target on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research report on Friday, September 20th. Stifel Nicolaus lifted their price target on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Finally, Northland Securities increased their price objective on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st.

Get Our Latest Research Report on Trupanion

Insiders Place Their Bets

In other Trupanion news, CFO Fawwad Qureshi sold 622 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total value of $32,723.42. Following the transaction, the chief financial officer now owns 9,867 shares of the company’s stock, valued at approximately $519,102.87. The trade was a 5.93 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Emily Dreyer sold 900 shares of the company’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $54.55, for a total value of $49,095.00. Following the completion of the transaction, the senior vice president now owns 23,808 shares of the company’s stock, valued at $1,298,726.40. This trade represents a 3.64 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,405 shares of company stock valued at $1,512,482. Corporate insiders own 5.50% of the company’s stock.

Institutional Trading of Trupanion

A number of large investors have recently added to or reduced their stakes in the stock. FMR LLC grew its position in shares of Trupanion by 55,963.7% during the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after acquiring an additional 1,170,202 shares during the period. Renaissance Technologies LLC bought a new position in Trupanion during the second quarter valued at $4,739,000. Wellington Management Group LLP increased its position in Trupanion by 4.4% in the third quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock worth $142,475,000 after buying an additional 142,156 shares during the last quarter. Hosking Partners LLP bought a new stake in shares of Trupanion in the second quarter valued at $3,523,000. Finally, Marshall Wace LLP raised its stake in shares of Trupanion by 11.9% in the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after buying an additional 116,496 shares during the period.

Trupanion Stock Performance

Shares of Trupanion stock opened at $54.15 on Friday. The business has a 50-day simple moving average of $52.58 and a 200 day simple moving average of $42.26. Trupanion has a one year low of $19.69 and a one year high of $57.90. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a market capitalization of $2.29 billion, a price-to-earnings ratio of -169.22 and a beta of 1.60.

Trupanion (NASDAQ:TRUPGet Free Report) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company had revenue of $327.50 million for the quarter, compared to analyst estimates of $321.79 million. During the same period in the prior year, the firm earned ($0.10) earnings per share. Trupanion’s revenue for the quarter was up 14.6% on a year-over-year basis. On average, research analysts anticipate that Trupanion will post -0.23 earnings per share for the current fiscal year.

About Trupanion

(Get Free Report

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Further Reading

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.